Document is current
Any future updates will be listed below
-
Authors
Khalique, Muhammad Irfan
Arjunan, Mousindha
Wood, Samuel
Mackie, Sarah L. http://orcid.org/0000-0003-2483-5873
- License Information
-
More Information
Article History
Received: 3 January 2024
Revised: 14 May 2024
Accepted: 22 May 2024
First Online: 19 June 2024
Competing interests
: SLM reports: Consultancy on behalf of her institution for Roche/Chugai, Sanofi, AbbVie, AstraZeneca, Pfizer; Investigator on clinical trials for Sanofi, GSK, Sparrow; speaking/lecturing on behalf of her institution for Roche/Chugai, Vifor, Pfizer, UCB, Novartis, AbbVie and Fresenius Kabi; chief investigator on STERLING-PMR trial, funded by NIHR; patron of the charity PMRGCAuk. No personal remuneration was received for any of the above activities. Support from Roche/Chugai to attend EULAR2019 in person and from Pfizer to attend ACR Convergence 2021 virtually. The views expressed in this article are those of the authors and not necessarily those of the NIHR, the NIHR Leeds Biomedical Research Centre, the National Health Service or the UK Department of Health and Social Care. Other authors: No conflicts disclosed.
